| 4.12 Data as of Jun 18 |  +0.07 / +1.73%Today’s Change | 3.16 Today|||52-Week Range 10.70 | -48.82% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $161.7M |
Company Description
Rockwell Medical Technologies, Inc. manufactures, sells and distributes hemodialysis concentrates and other ancillary medical products and supplies used in the treatment of patients with end stage renal disease. It supplies its products to medical service to cleanse patient's blood and replace nutrients lost during the kidney dialysis process. The company is currently developing unique, proprietary renal drugs to treat anemia and secondary hyperparathyroidism. It provides ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts and other supplies used by hemodialysis providers. Rockwell Medical manufactures and sells iron supplemented dialysate, which is used for the treatment of dialysis patients with iron deficiency that is pervasive in the dialysis patient population. The company was founded by Robert L. Chioini in October 1996 and is headquartered in Wixom, MI.
Employees
Shareholders
| Mutual fund holders | 4.76% |
| Other institutional | 23.16% |
| Individual stakeholders | 10.61% |
Top Executives
| Robert L. Chioini | Chairman, President & Chief Executive Officer |
| Thomas E. Klema, MBA, CPA | Chief Financial Officer, Secretary, Treasurer & VP |
| Ajay Gupta, MD | Chief Scientific Officer |
| Raymond D. Pratt, MD | Chief Medical Officer |
| Carl Belczynski, PhD | Vice President-Investor Relations |
.
